{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:18:47Z","timestamp":1790252327719,"version":"4.1.0"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,5]]},"DOI":"10.2967\/jnumed.124.268621","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:42:44Z","timestamp":1743147764000},"page":"726-731","source":"Crossref","is-referenced-by-count":8,"title":["PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy"],"prefix":"10.2967","volume":"66","author":[{"given":"Felix L.","family":"Herr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dascalescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias P.","family":"Fabritius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel T.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias J.","family":"Zacherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Wenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Unterrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Holzgreve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J.","family":"Auernhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Spitzweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Burkard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice M.","family":"Heimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens C.","family":"Cyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"2025050105251682000_66.5.726.1","doi-asserted-by":"publisher","DOI":"10.1267\/ahc.12006"},{"key":"2025050105251682000_66.5.726.2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0029"},{"key":"2025050105251682000_66.5.726.3","doi-asserted-by":"crossref","first-page":"102819","DOI":"10.1155\/2013\/102819","article-title":"Somatostatin receptor-based molecular imaging and therapy for neuroendocrine tumors","volume":"2013","author":"Wang","year":"2013","journal-title":"Biomed Res Int."},{"key":"2025050105251682000_66.5.726.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2123-y"},{"key":"2025050105251682000_66.5.726.5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-2007-1000400","article-title":"Defibrotide reduces monocyte PAI-2 and procoagulant activity","volume":"21","author":"Abbate","year":"1995","journal-title":"Semin Thromb Hemost."},{"key":"2025050105251682000_66.5.726.6","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.3390\/cancers15194836","article-title":"Monitoring and surveillance of patients with gastroenteropancreatic neuroendocrine tumors undergoing radioligand therapy","volume":"15","author":"Halfdanarson","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2025050105251682000_66.5.726.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.126177"},{"key":"2025050105251682000_66.5.726.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.091165"},{"key":"2025050105251682000_66.5.726.9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s00259-019-04501-6","article-title":"Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors","volume":"47","author":"Ilhan","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025050105251682000_66.5.726.10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122501"},{"key":"2025050105251682000_66.5.726.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1205-y"},{"key":"2025050105251682000_66.5.726.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2371-5"},{"key":"2025050105251682000_66.5.726.13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000475526","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues","volume":"105","author":"Hicks","year":"2017","journal-title":"Neuroendocrinology."},{"key":"2025050105251682000_66.5.726.14","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","article-title":"[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2\u20133, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet."},{"key":"2025050105251682000_66.5.726.15","doi-asserted-by":"publisher","DOI":"10.1159\/000471879"},{"key":"2025050105251682000_66.5.726.16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00261-021-03393-1","article-title":"Defining disease status in gastroenteropancreatic neuroendocrine tumors: Choi-criteria or RECIST?","volume":"47","author":"van Treijen","year":"2022","journal-title":"Abdom Radiol (NY)."},{"key":"2025050105251682000_66.5.726.17","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0365"},{"key":"2025050105251682000_66.5.726.18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/pharmaceutics14061278","article-title":"Comparison of Choi, RECIST and somatostatin receptor PET\/CT based criteria for the evaluation of response and response prediction to PRRT","volume":"14","author":"Zwirtz","year":"2022","journal-title":"Pharmaceutics."},{"key":"2025050105251682000_66.5.726.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.3049"},{"key":"2025050105251682000_66.5.726.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.240911"},{"key":"2025050105251682000_66.5.726.21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2967\/jnumed.117.206631","article-title":"SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: a proposed standardization framework","volume":"59","author":"Werner","year":"2018","journal-title":"J Nucl Med."},{"key":"2025050105251682000_66.5.726.22","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1007\/s00330-023-09518-y","article-title":"Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET\/CT and treatment planning in neuroendocrine tumor (NET) patients","volume":"33","author":"Grawe","year":"2023","journal-title":"Eur Radiol."},{"key":"2025050105251682000_66.5.726.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2330-6"},{"key":"2025050105251682000_66.5.726.24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.soc.2019.11.007","article-title":"Nuclear imaging of neuroendocrine tumors","volume":"29","author":"Pollard","year":"2020","journal-title":"Surg Oncol Clin."},{"key":"2025050105251682000_66.5.726.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2025050105251682000_66.5.726.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.081"},{"key":"2025050105251682000_66.5.726.27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics."},{"key":"2025050105251682000_66.5.726.28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/curroncol28010015","article-title":"Efficacy of 177Lu-Dotatate induction and maintenance therapy of various types of neuroendocrine tumors: a phase II registry study","volume":"28","author":"Sistani","year":"2020","journal-title":"Curr Oncol."},{"key":"2025050105251682000_66.5.726.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"2025050105251682000_66.5.726.30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12885-017-3150-7","article-title":"Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi criteria?","volume":"17","author":"Luo","year":"2017","journal-title":"BMC Cancer."},{"key":"2025050105251682000_66.5.726.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00572-6"},{"key":"2025050105251682000_66.5.726.32","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.3390\/cancers15184506","article-title":"Survival and response outcomes for gastrointestinal neuroendocrine tumor (GEP-NETs) patients treated with lutetium-177-DOTATATE in a Brazilian reference center: a six-year follow-up experience","volume":"15","author":"de Souza","year":"2023","journal-title":"Cancers (Basel)."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:26:08Z","timestamp":1746102368000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,1]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.2967\/jnumed.124.268621"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268621","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}